Detalhe da pesquisa
1.
Efficacy of Intravesical Nadofaragene Firadenovec for Patients with BCG-Unresponsive Non-muscle Invasive Bladder Cancer: 5 Year Follow-Up from a Phase 3 Trial.
J Urol
; : 101097JU0000000000004020, 2024 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38704840
2.
CREST: phase III study of sasanlimab and Bacillus Calmette-Guérin for patients with Bacillus Calmette-Guérin-naïve high-risk non-muscle-invasive bladder cancer.
Future Oncol
; 20(14): 891-901, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38189180
3.
Protocol of the Comparison of Intravesical Therapy and Surgery as Treatment Options (CISTO) study: a pragmatic, prospective multicenter observational cohort study of recurrent high-grade non-muscle invasive bladder cancer.
BMC Cancer
; 23(1): 1127, 2023 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37980511
4.
Utility of Blue Light Cystoscopy for Post-bacillus Calmette-Guérin Bladder Cancer Recurrence Detection: Implications for Clinical Trial Recruitment and Study Comparisons.
J Urol
; 207(3): 534-540, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34694916
5.
Role of blue-light cystoscopy in detecting invasive bladder tumours: data from a multi-institutional registry.
BJU Int
; 130(1): 62-67, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34637596
6.
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
Lancet Oncol
; 22(1): 107-117, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33253641
7.
Update on the guideline of guidelines: non-muscle-invasive bladder cancer.
BJU Int
; 125(2): 197-205, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31597003
8.
ENERGIZE: a Phase III study of neoadjuvant chemotherapy alone or with nivolumab with/without linrodostat mesylate for muscle-invasive bladder cancer.
Future Oncol
; 16(2): 4359-4368, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31823654
9.
Development and evaluation of a bladder Cancer specific survivorship care plan by patients and clinical care providers: a multi-methods approach.
BMC Health Serv Res
; 20(1): 686, 2020 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32709234
10.
The Impact of Omission of Intraoperative Frozen Section Prior to Orthotopic Neobladder Reconstruction.
J Urol
; 202(4): 763-769, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31059666
11.
Emerging therapies in the management of high-risk non-muscle invasive bladder cancer (HRNMIBC).
World J Urol
; 37(10): 2031-2040, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30515595
12.
Current Clinical Trials in Non-muscle-Invasive Bladder Cancer: Heightened Need in an Era of Chronic BCG Shortage.
Curr Urol Rep
; 20(12): 84, 2019 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31781942
13.
Fistulous Complications following Radical Cystectomy for Bladder Cancer: Analysis of a Large Modern Cohort.
J Urol
; 199(3): 663-668, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28859892
14.
Non-muscle-invasive bladder cancer: Intravesical treatments beyond Bacille Calmette-Guérin.
Cancer
; 123(3): 390-400, 2017 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28112819
15.
Extended Duration Enoxaparin Decreases the Rate of Venous Thromboembolic Events after Radical Cystectomy Compared to Inpatient Only Subcutaneous Heparin.
J Urol
; 197(2): 302-307, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27569434
16.
Redefining the implications of nasogastric tube placement following radical cystectomy in the alvimopan era.
World J Urol
; 35(4): 625-631, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27476163
17.
Editorial Comment.
J Urol
; 206(5): 1266-1267, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34372684
18.
Editorial Comment.
J Urol
; 205(6): 1619-1620, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33734860
19.
20.
Bladder Cancer Mortality in the United States: A Geographic and Temporal Analysis of Socioeconomic and Environmental Factors.
J Urol
; 195(2): 290-6, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26235377